A review of the molecular conformations of melatonin ligands at the melatonin receptor

This review examines the 1992-2000 literature on studies of the molecular conformations of melatonin ligands at the melatonin receptor. In order to investigate quantitative structure-affinity relationships between different chemical classes of melatonergic ligands binding to the melatonin GPCR, CoMFA has been applied to extended sets of compounds, to obtain 3D-QSAR agonist/antagonist models. The results of several authors have suggested that the active conformation of the C-3 aminoethyl side chain of melatonin and related compounds is in a folded form, orthogonal to the aromatic ring. Positive steric potentials were found in the C-2 region, surrounding the C-5 methoxy group and near the N -acyl group of the side chain, while substituents in positions C-6 and C-7 cause a decrease in affinity. Negative steric regions were found between indole N-1 and C-2. Receptor binding affinities have been predicted for a range of structurally diverse compounds for the sheep brain melatonin receptor considering steric, electrostatic and lipophilic fields.

[1]  D. Lesieur,et al.  A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice , 1999, Brain Research.

[2]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[3]  R. Nonno,et al.  Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study. , 1998, Journal of medicinal chemistry.

[4]  D. Sugden,et al.  Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles. , 1998, Journal of medicinal chemistry.

[5]  D. Kennaway,et al.  Melatonin binding sites: Are they receptors? , 1992, Molecular and Cellular Endocrinology.

[6]  L Morin-Allory,et al.  Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors. , 1998, Journal of medicinal chemistry.

[7]  H. Kubinyi.  Comparative Molecular Field Analysis (CoMFA) , 2002 .

[8]  J. Jansen,et al.  The high affinity melatonin binding site probed with conformationally restricted ligands--II. Homology modeling of the receptor. , 1996, Bioorganic & medicinal chemistry.

[9]  A. Gubitz,et al.  Chimeric and point-mutated receptors reveal that a single glycine residue in transmembrane domain 6 is critical for high affinity melatonin binding. , 2000, Endocrinology.

[10]  D. Kennaway,et al.  Mechanisms of action of melatonin within the central nervous system , 1992 .

[11]  A. Tsotinis,et al.  Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides. , 1996, Journal of medicinal chemistry.

[12]  A. Tsotinis,et al.  Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles. , 2000, Journal of medicinal chemistry.

[13]  M. Langlois,et al.  Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis study. , 1997, Journal of medicinal chemistry.

[14]  Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles. , 2000 .

[15]  S. Dowell,et al.  Mutagenesis of human Mel1a melatonin receptor expressed in yeast reveals domains important for receptor function. , 1998, Biochemical and biophysical research communications.

[16]  R. Nonno,et al.  Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study. , 1997, Journal of medicinal chemistry.

[17]  D. Kennaway,et al.  Structure-activity studies of melatonin analogues in prepubertal male rats. , 1988, Australian journal of biological sciences.

[18]  M. Young.  The tick-tock of the biological clock. , 2000, Scientific American.

[19]  P. Morgan,et al.  The roles of valine 208 and histidine 211 in ligand binding and receptor function of the ovine Mel1a beta melatonin receptor. , 1997, Biochemical and biophysical research communications.

[20]  P. Zee,et al.  Serotonin in the spotlight , 1997, Nature.

[21]  Paolo Sassone-Corsi,et al.  Molecular clocks: mastering time by gene regulation , 1998, Nature.

[22]  A. Poso,et al.  A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. , 1996, European journal of pharmacology.